- Filed
- May 5, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 84.64M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $546.43M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $560.94M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $34.28M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $34.44M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $271.94M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $281.31M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $130.77M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $118.35M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $316.49M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $326.15M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.05B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.05B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 85.3M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $6.12M |
| Capex | Q1 2025 · Mar 31, 2024 | $20.64M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $28.75M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $202.13M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $198.4M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.09 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.09 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $47.63M |
| Net Income | Q1 2025 · Mar 31, 2024 | $7.42M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $25.56M |